BOPPY-based novel fluorescent dopamine D2 and D3 receptor ligands

被引：9
作者：
Elek, Milica [1 ]
Dubiel, Mariam [1 ]
Mayer, Laura [2 ]
Zivkovic, Aleksandra [1 ]
Mueller, Thomas J. J. [2 ]
Stark, Holger [1 ]
机构：
[1] Heinrich Heine Univ Dusseldorf, Inst Pharmaceut & Med Chem, Univ Str 1, D-40225 Dusseldorf, Germany
[2] Heinrich Heine Univ Dusseldorf, Inst Organ Chem, Univ Str 1, D-40225 Dusseldorf, Germany
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2022年 / 59卷
关键词：
Dopamine; BOPPY; D2R; D3R; Fluorescence; Ligands; HIGHLY FLUORESCENT; HIGH-AFFINITY; BODIPY DYES; D3; SCHIZOPHRENIA; BIOLOGY; BINDING; PROBES; TARGET;
D O I：
10.1016/j.bmcl.2022.128573
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Dopamine is one of the crucial neurotransmitters in the human brain. Its out-of-range concentration can lead to various neurological diseases with special interest for dopamine D-2 and D-3 receptor subtypes. Although BODIPY is a highly versatile structural moiety for fluorescence labeling, we have looked out for structurally related pyridine-based moieties. We used BOPPY labelling of well-described D2R/D3R pharmacophores to obtain ligands with moderate to low nanomolar binding affinities as well as low to excellent quantum yields for bright fluorescence ligands. To best of our knowledge, this is the first report on the application of BOPPY fluorophores to GPCR ligands. This approach offers a general applicable way for fluorescence labelling via primary aliphatic amine elements.
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
    Ragy R. Girgis
    Mark Slifstein
    Deepak D’Souza
    Yih Lee
    Antonia Periclou
    Parviz Ghahramani
    István Laszlovszky
    Suresh Durgam
    Nika Adham
    Nabeel Nabulsi
    Yiyun Huang
    Richard E. Carson
    Béla Kiss
    Margit Kapás
    Anissa Abi-Dargham
    Ashok Rakhit
    Psychopharmacology, 2016, 233 : 3503 - 3512
  • [42] Preferential binding to dopamine D3 over D2 receptors by cariprazine in patients with schizophrenia using PET with the D3/D2 receptor ligand [11C]-(+)-PHNO
    Girgis, Ragy R.
    Slifstein, Mark
    D'Souza, Deepak
    Lee, Yih
    Periclou, Antonia
    Ghahramani, Parviz
    Laszlovszky, Istvan
    Durgam, Suresh
    Adham, Nika
    Nabulsi, Nabeel
    Huang, Yiyun
    Carson, Richard E.
    Kiss, Bela
    Kapas, Margit
    Abi-Dargham, Anissa
    Rakhit, Ashok
    PSYCHOPHARMACOLOGY, 2016, 233 (19-20) : 3503 - 3512
  • [43] Midbrain dopamine D2/3 receptor binding in schizophrenia
    Tuppurainen, Heli
    Kuikka, Jyrki T.
    Laakso, Mikko P.
    Viinamaki, Heimo
    Husso, Minna
    Tiihonen, Jari
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2006, 256 (06) : 382 - 387
  • [44] Midbrain dopamine D2/3 receptor binding in schizophrenia
    Heli Tuppurainen
    Jyrki T. Kuikka
    Mikko P. Laakso
    Heimo Viinamäki
    Minna Husso
    Jari Tiihonen
    European Archives of Psychiatry and Clinical Neuroscience, 2006, 256 : 382 - 387
  • [45] Drugs for psychosis and mood: unique actions at D3, D2, and D1 dopamine receptor subtypes
    Stahl, Stephen M.
    CNS SPECTRUMS, 2017, 22 (05) : 375 - 384
  • [46] Design, Synthesis and Pharmacological Evaluation of Novel Conformationally Restricted N-arylpiperazine Derivatives Characterized as D2/D3 Receptor Ligands, Candidates for the Treatment of Neurodegenerative Diseases
    da Silva Cunha, Thayssa Tavares
    Silva, Rafaela Ribeiro
    Rodrigues, Daniel Alencar
    Murteira Pinheiro, Pedro de Sena
    Kronenberger, Thales
    Sant'Anna, Carlos Mauricio R.
    Noel, Francois
    Manssour Fraga, Carlos Alberto
    BIOMOLECULES, 2022, 12 (08)
  • [47] Reading abilities and dopamine D2/D3 receptor availability: An inverted U-shaped association in subjects with schizophrenia
    Mitelman, Serge A.
    Buchsbaum, Monte S.
    Vyas, Nora S.
    Christian, Bradley T.
    Merrill, Brian M.
    Buchsbaum, Bradley R.
    Mitelman, Alexis M.
    Mukherjee, Jogeshwar
    Lehrer, Douglas S.
    BRAIN AND LANGUAGE, 2021, 223
  • [48] Functional potencies of dopamine agonists and antagonists at human dopamine D2 and D3 receptors
    Tadori, Yoshihiro
    Forbes, Robert A.
    McQuade, Robert D.
    Kikuchi, Tetsuro
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 666 (1-3) : 43 - 52
  • [49] Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo
    Beaulieu, Jean-Martin
    Tirotta, Emanuele
    Sotnikova, Tatyana D.
    Masri, Bernard
    Salahpour, Ali
    Gainetdinov, Raul R.
    Borrelli, Emiliana
    Caron, Marc G.
    JOURNAL OF NEUROSCIENCE, 2007, 27 (04) : 881 - 885
  • [50] New ligands for the D3 dopaminergic receptor
    Mann, A
    Wermuth, CG
    ACTUALITE CHIMIQUE, 2003, (4-5): : 93 - 96
12345